IASIS PHARMA announces the launch of MAG-IASIS®, the first uniquely effective combination indicated for magnesium deficiency in the form of effervescent tablets. Each effervescent tablet of MAG-IASIS® contains: 1193.57 mg magnesium citrate & 667.56 mg magnesium aspartate equivalent to 243 mg Magnesium. MAG-IASIS® main indications are: ● magnesium deficiency, under the condition that it cannot [...]
IASIS PHARMA has launched a new pharmaceutical product under the brand name of ZALEPIN® RAPID, enriching its CNS product portfolio. ZALEPIN® RAPID contains Olanzapine as its active ingredient and belongs to the class of atypical antipsychotic agents, the newer generation of antipsychotics. ZALEPIN® RAPID is available in the form of orodispersible tablets (ODT), offering the [...]
DIVANI CARAVEL HOTEL, ATHENS, 2-3/12/2017 ΙΑSIS PHARMA successfully participated in the 15th 2-Day Educational Workshop on Functional Diseases of the Peptic System, which took place at Divani - Caravel Hotel in Athens, December 2 - 3, 2017. The event was organized by the Professional Association of Greek Gastroenterologists (EPEGE). The workshop focused on the diseases [...]
TITANIA HOTEL, ATHENS, 24-25/11/2017 IASIS PHARMA actively contributed as a sponsor to the 2nd Training Seminar, under the title: "HEART, DIABETES AND MUSCULOSCELETAL SYSTEM - ALL THE LATEST DEVELOPMENTS". The event took place at Titania Hotel Athens, November 24-25th 2017 and was organized by the Freelance Doctors Union of ATTICA region.
MACEDONIA PALACE HOTEL, THESSALONIKI, 2-5/11/2017 From November 3rd to 6th 2017, the Hellenic Society of Dermatology and Venereology (EDAE) held the 13th Panhellenic Conference of Dermatology & Venereology, at Makedonia Palace hotel, in Thessaloniki, capital of Northern Greece, Macedonia. IASIS PHARMA was present, attending the conference with success. The conference aimed to update dermatologists on [...]
MESSE FRANKFURT, FRANKFURT, 24-26/10/2017 IASIS PHARMA successfully participated as an exhibitor and for the third sequential year in CPhI Worldwide, the most important international pharmaceutical trade fair. For 2017, CPhI was held in the exhibition center “Frankfurt Messe”, at Frankfurt, Germany, from October 24th to 26th. During the exhibition, IASIS PHARMA team had the chance [...]
MAKEDONIA PALACE HOTEL, THESSALONIKI, 5-8/10/2017 ΙΑSIS PHARMA participated dynamically in the 37th Panhellenic Gastroenterology Conference, which took place at Makedonia Palace Hotel, in Thessaloniki, Macedonia, November 24-27th 2016 and was organized by the Hellenic Society of Gastroenterology (E.G.E). The Panhellenic Gastroenterology Conference constitutes the top scientific event of E.G.E, aiming to update and educate every [...]
IASIS PHARMA and its subsidiary company Pharma Q, Chios Mastiha Growers Association and its subsidiary Mediterra, and Pharmagnose, the spin-off company of the Faculty of Pharmacy - University of Athens, join forces setting Greek nature as a focal point, by establishing the unique Chios Mastiha Research & Development Center. Manufactured with pharmaceutical industry standards, the [...]
Always committed to continuous growth, IASIS PHARMA purchased at 2016 a 45.000m2 property in Attica, in order to construct new, larger and more efficient facilities. The new property will combine 3 Dedicated and Separated Production Facilities, Research & Development Center, administrative offices and 2.500m2 state-of-the-art Warehousing facilities. The new Production Facilities are planned in compliance [...]
Vari’s Elderly Care Unit, Attica 13-14/06/2017 IASIS PHARMA, always loyal to its social corporate responsibility and support to medical experts and patients, cooperated with the Greek association for skeletal health “Petalouda” (Petalouda stands for Butterfly in Greek), carrying out an event to inform people about preventing and confronting osteoporosis. The event was carried out at [...]
